Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

[Combination drug therapy in patients with BPH].

Kuzmenko AV, Kuzmenko VV, Gyaurgiev TA.

Urologiia. 2018 Mar;(1):101-105. Russian.

PMID:
29634142
2.

[Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines].

Vinarov AZ, Spivak LG, Mironov AV.

Urologiia. 2017 Sep;(4):120-128. Russian.

PMID:
28952704
3.

Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I Studies.

Fossler M, Zhu J, Roehrborn C, McAleese P, Manyak M.

Clin Drug Investig. 2016 Sep;36(9):763-767. doi: 10.1007/s40261-016-0419-6.

PMID:
27356530
4.

Effect of tamsulosin on the pharmacokinetics of dutasteride in Chinese male healthy volunteers.

Li H, Yang J, Zhao H, Fossler MJ, Wang C.

Clin Pharmacol Drug Dev. 2015 Nov;4(6):427-33. doi: 10.1002/cpdd.197. Epub 2015 Jul 20.

PMID:
27137714
5.
7.

5α-reductase type 1 modulates insulin sensitivity in men.

Upreti R, Hughes KA, Livingstone DE, Gray CD, Minns FC, Macfarlane DP, Marshall I, Stewart LH, Walker BR, Andrew R.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1397-406. doi: 10.1210/jc.2014-1395. Epub 2014 May 13.

8.

Nocturia improvement in the combination of Avodart(®) and tamsulosin (CombAT) study.

Oelke M, Roehrborn CG, D'Ancona C, Wilson TH, Castro R, Manyak M.

World J Urol. 2014 Oct;32(5):1133-40. doi: 10.1007/s00345-014-1296-3. Epub 2014 May 8.

PMID:
24804842
9.

Pharmacokinetic bioequivalence studies of a fixed-dose combination of tamsulosin and dutasteride in healthy volunteers.

Fossler MJ, Collins DA, Thompson MM, Nino A, Bianco JJ, Chetty D.

Clin Drug Investig. 2014 May;34(5):335-49. doi: 10.1007/s40261-014-0179-0.

PMID:
24615171
12.

Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.

Chung BH, Lee SH, Roehrborn CG, Siami PF, Major-Walker K, Wilson TH, Montorsi F; CombAT Study Group.

Int J Urol. 2012 Nov;19(11):1031-5. doi: 10.1111/j.1442-2042.2012.03091.x. Epub 2012 Jul 9.

13.

Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial.

Roehrborn CG, Wilson TH, Black LK.

J Urol. 2012 May;187(5):1732-8. doi: 10.1016/j.juro.2011.12.083. Epub 2012 Mar 15.

PMID:
22425127
14.

The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study.

Haillot O, Fraga A, Maciukiewicz P, Pushkar D, Tammela T, Höfner K, Chantada V, Gagnier P, Morrill B.

Prostate Cancer Prostatic Dis. 2011 Dec;14(4):302-6. doi: 10.1038/pcan.2011.13. Epub 2011 Apr 19.

PMID:
21502969
15.

The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study.

Montorsi F, Roehrborn C, Garcia-Penit J, Borre M, Roeleveld TA, Alimi JC, Gagnier P, Wilson TH.

BJU Int. 2011 May;107(9):1426-31. doi: 10.1111/j.1464-410X.2011.10129.x. Epub 2011 Feb 23.

16.
17.

Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.

Roehrborn CG, Andriole GL, Wilson TH, Castro R, Rittmaster RS.

Eur Urol. 2011 Feb;59(2):244-9. doi: 10.1016/j.eururo.2010.10.040. Epub 2010 Nov 4.

PMID:
21093145
18.

Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 4-year data from the CombAT study.

Montorsi F, Henkel T, Geboers A, Mirone V, Arrosagaray P, Morrill B, Black L.

Int J Clin Pract. 2010 Jul;64(8):1042-51. doi: 10.1111/j.1742-1241.2010.02428.x. Epub 2010 May 7.

PMID:
20487046
19.

Operating characteristics of a partial-block randomized crossover bioequivalence study for dutasteride, a drug with a long half-life: investigation through simulation and comparison with final results.

Cai G, Thiessen JJ, Baidoo CA, Fossler MJ.

J Clin Pharmacol. 2010 Oct;50(10):1142-50. doi: 10.1177/0091270009355155. Epub 2010 Feb 16.

PMID:
20160156
20.

The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study.

Becher E, Roehrborn CG, Siami P, Gagnier RP, Wilson TH, Montorsi F.

Prostate Cancer Prostatic Dis. 2009;12(4):369-74. doi: 10.1038/pcan.2009.37. Epub 2009 Sep 1.

PMID:
19901936

Supplemental Content

Loading ...
Support Center